| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |